ESR1 and breast cancer: Although in some cases of human basal-like breast cancer NG2 is reportedly expressed by tumor cells that are triple-negative for estrogen receptor, progesterone receptor, and HER2 [18,19], we have found that NG2 is not expressed by mammary tumor cells in the MMTV-PyMT mouse [11,20].